Smart Mice, Not-So-Smart People: An Interesting and Amusing Guide to Bioethics | 
| Author: Arthur Caplan
Publisher: Rowman & Littlefield Publishers, Inc.
Category: Book
List Price: $14.95
Buy New: $8.95
You Save: $6.00 (40%)
New (19) Used (4) from $8.95
Avg. Customer Rating:  1 reviews
Sales Rank: 570080
Media: Paperback
Number Of Items: 1
Pages: 224
Shipping Weight (lbs): 0.8
Dimensions (in): 8.9 x 6 x 0.7
ISBN: 074254172X
Dewey Decimal Number: 174
EAN: 9780742541726
ASIN: 074254172X
Publication Date: March 25, 2008
Availability: Usually ships in 1-2 business days
Shipping: International shipping available
Condition: Brand New, Perfect Condition, Please allow 4-14 business days for delivery. 100% Money Back Guarantee, Over 1,000,000 customers served.
|
| Also Available In:
|
| Similar Items:
|
| Editorial Reviews:
Product Description
Famed bioethicist Arthur Caplan shares his provocative opinions on all things bioethical.
|
| Customer Reviews:
Provocative and Amusing Essays December 1, 2006
9 out of 11 found this review helpful
Art Caplan provides a practical, easily grasped guide to today's controversial high tech medical issues at a time when scientific discovery is outpacing existing policy and yesterday's paradigms. His provocative and amusing essays range from cloning to engineering ourselves. His essay on brain enhancement brings it home when he frames the morality in the context of sending his son, Zach, to private school concluding that people want to optimize their brains.
Caplan is a visionary leader in the field of bioethics. This new academic discipline is as critical to biotechnology as is groundbreaking scientific research. If Americans are going to benefit from scientific breakthroughs of the new millennium such as the mapping of the human genome, gene therapy and stem cell research, we must have excellent communications between the scientific community and society.
Smart Mice, Not So Smart People provides that critical communications bridge. Caplan has a unique ability to communicate to the academic community, the biotech industry, the decision-makers in Washington, the media, and the general public. Without the understanding and participation of each cluster of this mosaic, we will not be able to transform scientific advances to medical treatments in a timely manner. Nor will the necessary funding for cutting edge research be forthcoming if the societal issues are not integrated into the equation.
|
|
|
